Evidence map›Paper›PMID 36181415›Full record

ArticlePest management science2022

Anticoagulant rodenticide blood-clotting dose-responses and resistance factors for Tyrosine139Cysteine (Y139C) heterozygous- and homozygous-resistant house mice (Mus musculus).

Mhairi Alyson Baxter, Alan Peter Buckle, Stefan Endepols, Colin Vittorio Prescott

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Pest management science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mhairi Alyson BaxterSchool of Biological Sciences, Health and Life Sciences Building, The University of Reading, Reading, UK.ORCID https://orcid.org/0000-0001-7514-1826
Alan Peter BuckleSchool of Biological Sciences, Health and Life Sciences Building, The University of Reading, Reading, UK.ORCID https://orcid.org/0000-0002-5449-9279
Stefan EndepolsBayer AG CropScience, Research and Development Public Health, Monheim, Germany.ORCID https://orcid.org/0000-0002-1164-9695
Colin Vittorio PrescottSchool of Biological Sciences, Health and Life Sciences Building, The University of Reading, Reading, UK.ORCID https://orcid.org/0000-0002-2053-8292
University of Reading · GBBayer (Germany) · DE

Funding

Rodenticide Resistance Action Committee, CropLife InternationalUniversity of Reading
6 · The paper itself

Abstract

backgroundThe house mouse (Mus musculus) is a globally distributed rodent pest species against which anticoagulant rodenticides are widely used for the protection of human and animal health and the conservation of threatened wildlife. Anticoagulant-resistant house mice have been known for more than half a century. A house mouse strain was developed in the laboratory that was homozygous resistant for the single nucleotide polymorphism (SNP) Tyrosine139Cysteine (Y139C) and, subsequently, heterozygous resistant animals were produced from this strain by crossing with the homozygous susceptible strain.

resultsUsing blood clotting response tests, resistance factors at the ED

conclusionY139C SNP homozygous resistant mice are more resistant to anticoagulants than heterozygous resistant animals. All first-generation anticoagulants are highly resisted and, among the second-generation compounds, Y139C mice are resistant to bromadiolone and sometimes to difenacoum. © 2022 The Authors. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

Indexed as

4-HydroxycoumarinsRodenticidesAnimalsAnticoagulantsBlood CoagulationFemaleHeterozygoteHomozygoteHumansMaleMiceR FactorsRodentiaWarfarin4-HydroxycoumarinsAnticoagulantsRodenticidesWarfarinAnticoagulant resistanceblood clotting response testhouse mouseresistance factorTyrosine139CysteineY139C

Identifiers

PMID36181415
OpenAlexW4288704161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.